SinoMab BioScience Limited: SinoMab Announces Appointment of

HONG KONG, Nov 4, 2022 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical

Related Keywords

China , Tianqing , Zhejiang , Shanghai , Kostenloser Wertpapierhandel , Chia Tai , Sinomab Bioscience , Sino Biopharmaceutical , Shanghai Technology Advancement First Honour Award , Significant New Drugs Development Of The Twelfth , Tianqing Pharmaceutical Group Co , Jiangsu Province Technology Advanced Worker , Our Group , Sinomab Bioscience Limited , Mab Bioscience Limited , Hong Kong Based , Sino Biopharmaceutical Limited , Pharmaceutical Group , State Council , Jiangsu Province Model Labour , Jiangsu Province Outstanding Entrepreneur , Jiangsu Province Young , Middle Aged Expert , Outstanding Contribution , Jiangsu Advanced Individual , Significant New Drugs Development , Twelfth Five Year Plan Period , Thirteenth Five Year Plan , Sinomab , Ioscience , Imited , Nnounces , Appointment , Hanchun , Gang , President , Company ,